CHC
VIVO

City Holding Co’s Meridian Bioscience Inc VIVO Stock Holding History

City Holding Co’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,210
Closed -$17K – 601
2017
Q3 		$17K Hold
1,210
– – 0.01% 353
2017
Q2 		$19K Hold
1,210
– – 0.01% 352
2017
Q1 		$17K Buy
+1,210
New +$16.9K 0.01% 363

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

City Holding Co's VIVO Position: Q4 2017 in Review

City Holding Co sold out of Meridian Bioscience Inc (VIVO) in Q4 2017, closing a stake of 1,210 shares — an estimated $17K sold.

City Holding Co first reported a position in VIVO in Q1 2017 and held it in 3 quarters. The position peaked at $19K in Q2 2017. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

  • City Holding Co reported no remaining Meridian Bioscience Inc position as of Q4 2017 after selling out during the quarter.
  • City Holding Co sold 1,210 Meridian Bioscience Inc shares in Q4 2017, an estimated $17K.
  • City Holding Co first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 3 quarters.
  • City Holding Co's Meridian Bioscience Inc position peaked at $19K in Q2 2017.
  • 178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on City Holding Co's 13F filing for Q4 2017, filed 17 Jan 2018.